6-hydroxytryptamine has been researched along with hemicholinium 3 in 1 studies
Studies (6-hydroxytryptamine) | Trials (6-hydroxytryptamine) | Recent Studies (post-2010) (6-hydroxytryptamine) | Studies (hemicholinium 3) | Trials (hemicholinium 3) | Recent Studies (post-2010) (hemicholinium 3) |
---|---|---|---|---|---|
19 | 0 | 0 | 963 | 1 | 34 |
Protein | Taxonomy | 6-hydroxytryptamine (IC50) | hemicholinium 3 (IC50) |
---|---|---|---|
Vesicular acetylcholine transporter | Homo sapiens (human) | 0.012 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beleslin, DB; Krstić, SK | 1 |
1 other study(ies) available for 6-hydroxytryptamine and hemicholinium 3
Article | Year |
---|---|
Dimethylphenylpiperazinium-induced vomiting: nicotinic mediation in area postrema.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Cats; Cerebral Ventricles; Copper; Copper Sulfate; Dimethylphenylpiperazinium Iodide; Dopamine Antagonists; Female; Ganglionic Blockers; Hemicholinium 3; Histamine H1 Antagonists; Hydroxydopamines; Male; Oxidopamine; Parasympatholytics; Piperazines; Receptors, Nicotinic; Reserpine; Serotonin; Serotonin Antagonists; Vomiting | 1986 |